Pharmaron Beijing 康龙化成
19 significant filings since 29 May 2026: 1 on share pledge, 7 on equity incentive and 3 on pledge released, and 5 other kinds. The latest, on 22 Sep 2026: 关于公司实际控制人的一致行动人部分股份解除质押的公告. On 13 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 4.00% to 10.00% from the same period a year earlier.
自 29 May 2026 起有 19 份重大公告：share pledge 1 份、equity incentive 7 份、pledge released 3 份，另有 5 类。最新一份（22 Sep 2026）：关于公司实际控制人的一致行动人部分股份解除质押的公告。13 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 4.00% 至 10.00%。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 1.10 | 1.47 |
| 7 days ago | 1.10 | 1.47 |
| 30 days ago | 1.10 | 1.47 |
| 60 days ago | 1.12 | 1.36 |
| 90 days ago | 1.14 | 1.36 |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 1.33 in Sep 2024 to 1.10 in Sep 2026 (-17.3%). 一致预期从 Sep 2024 的 1.33 变为 Sep 2026 的 1.10 (-17.3%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
| Last 90 days | ▲ 0 ▼ 1 = 2 | ▲ 2 ▼ 0 = 1 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 0.